Not to mention that clarity are designing a trial in earlier disease patients. To be deciding this so early in the piece means they're extremely confident of the efficacy results, not just safety.
Ann: SECuRE trial advances, page-25
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.57 |
Change
0.195(2.65%) |
Mkt cap ! $2.371B | |||
| Open | High | Low | Value | Volume |
| $7.55 | $7.68 | $7.35 | $6.547M | 867.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 5528 | $7.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.57 | 2826 | 13 |
View Market Depth
| Last trade - 14.10pm 12/09/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |